In the past week, OMER stock has gone up by 44.89%, with a monthly gain of 57.49% and a quarterly surge of 59.80%. The volatility ratio for the week is 4.74%, and the volatility levels for the last 30 days are 4.43% for Omeros Corporation The simple moving average for the last 20 days is 49.35% for OMER stock, with a simple moving average of 63.88% for the last 200 days.
Is It Worth Investing in Omeros Corporation (NASDAQ: OMER) Right Now?
Moreover, the 36-month beta value for OMER is 1.48. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OMER is 55.36M and currently, short sellers hold a 21.64% of that float. On November 14, 2024, OMER’s average trading volume was 243.13K shares.
OMER) stock’s latest price update
Omeros Corporation (NASDAQ: OMER) has seen a rise in its stock price by 55.61 in relation to its previous close of 4.19. However, the company has experienced a 44.89% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2024-11-13 that Omeros Corporation (NASDAQ:OMER ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Jennifer Cook Williams – Investor and Media relations, Cook Williams Communications, Inc. Gregory Demopulos – Chairman and Chief Executive Officer David Borges – Chief Accounting Officer Andreas Grauer – Chief Medical Officer Steven Whitaker – Vice President, Clinical Development Conference Call Participants Steve Brozak – WBB Olivia Brayer – Cantor Fitzgerald Serge Belanger – Needham & Company Operator Good afternoon, and welcome to today’s conference call for Omeros Corporation. At this time, all participants are in a listen-only mode.
Analysts’ Opinion of OMER
UBS, on the other hand, stated in their research note that they expect to see OMER reach a price target of $2, previously predicting the price at $12. The rating they have provided for OMER stocks is “Neutral” according to the report published on December 08th, 2022.
BofA Securities gave a rating of “Underperform” to OMER, setting the target price at $3 in the report published on November 08th of the previous year.
OMER Trading at 60.10% from the 50-Day Moving Average
After a stumble in the market that brought OMER to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 14.79% of gains for the given period.
Volatility was left at 4.43%, however, over the last 30 days, the volatility rate increased by 4.74%, as shares surge +63.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +70.96% upper at present.
During the last 5 trading sessions, OMER rose by +50.45%, which changed the moving average for the period of 200-days by +108.95% in comparison to the 20-day moving average, which settled at $4.38. In addition, Omeros Corporation saw 99.39% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OMER starting from Demopulos Gregory A MD, who purchase 15,000 shares at the price of $1.68 back on Nov 17 ’23. After this action, Demopulos Gregory A MD now owns 123,945 shares of Omeros Corporation, valued at $25,200 using the latest closing price.
Demopulos Peter A MD, the Director of Omeros Corporation, purchase 10,000 shares at $1.53 during a trade that took place back on Nov 15 ’23, which means that Demopulos Peter A MD is holding 208,516 shares at $15,300 based on the most recent closing price.
Stock Fundamentals for OMER
Current profitability levels for the company are sitting at:
- -126.91 for the present operating margin
- 0.55 for the gross margin
The net margin for Omeros Corporation stands at -98.48. The total capital return value is set at -0.67. Equity return is now at value -576.33, with -45.24 for asset returns.
Based on Omeros Corporation (OMER), the company’s capital structure generated -3.15 points at debt to capital in total, while cash flow to debt ratio is standing at -1.32. The debt to equity ratio resting at -0.76. The interest coverage ratio of the stock is -8.47.
Currently, EBITDA for the company is -163.61 million with net debt to EBITDA at -0.7. When we switch over and look at the enterprise to sales, we see a ratio of 345.03. The receivables turnover for the company is 0.01for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.41.
Conclusion
To wrap up, the performance of Omeros Corporation (OMER) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
